Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Zydus Lifesciences LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532321NSE Symbol: ZYDUSLIFEP/E(TTM):18.37
ISIN Demat:INE010B01027Div & Yield %:1.25EPS(TTM):47.96
Book Value(Rs):215.0764496Market Cap ( Cr.):88659.28Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 100.60100.60101.20102.40102.40102.40
Reserves Total 21089.5015615.9013538.2013138.1012642.1011157.80
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds21190.1015716.5013639.4013240.5012744.5011260.20
Secured Loans 2149.500.000.00500.00383.90356.90
Unsecured Loans 6192.706178.304825.302164.703536.003337.80
Total Debt8342.206178.304825.302664.703919.903694.70
Other Liabilities265.60209.70166.20191.30179.20132.70
Total Liabilities29797.9022104.5018630.9016096.5016843.6015087.60
APPLICATION OF FUNDS :      
Gross Block 8899.608677.407999.807675.607009.106564.20
Less : Accumulated Depreciation 4697.504308.003815.703339.702897.102455.20
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 4202.104369.404184.104335.904112.004109.00
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress1188.50633.90739.30384.00570.50552.60
Producing Properties0.000.000.000.000.000.00
Investments 11491.507283.004879.305118.006470.606404.10
Current Assets, Loans & Advances      
Inventories 1952.101687.301782.401926.301780.001394.70
Sundry Debtors 8161.804740.103505.302277.701903.802456.70
Cash and Bank144.10414.40248.10302.60154.00385.30
Loans and Advances 820.201069.501420.802110.302193.90556.00
Total Current Assets11078.207911.306956.606616.906031.704792.70
Less : Current Liabilities and Provisions      
Current Liabilities 1869.101669.201539.301384.501401.701195.10
Provisions 504.30252.80199.10105.90111.0070.50
Total Current Liabilities2373.401922.001738.401490.401512.701265.60
Net Current Assets8704.805989.305218.205126.504519.003527.10
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets195.70179.90112.00136.60129.7092.20
Deferred Tax Liability341.30238.20306.30289.70237.00290.50
Net Deferred Tax-145.60-58.30-194.30-153.10-107.30-198.30
Other Assets4356.603887.203804.301285.201278.80693.10
Total Assets29797.9022104.5018630.9016096.5016843.6015087.60
Contingent Liabilities154.00111.00319.901797.101503.903690.30